JP2018507254A5 - - Google Patents

Download PDF

Info

Publication number
JP2018507254A5
JP2018507254A5 JP2017558627A JP2017558627A JP2018507254A5 JP 2018507254 A5 JP2018507254 A5 JP 2018507254A5 JP 2017558627 A JP2017558627 A JP 2017558627A JP 2017558627 A JP2017558627 A JP 2017558627A JP 2018507254 A5 JP2018507254 A5 JP 2018507254A5
Authority
JP
Japan
Prior art keywords
seq
variable region
chain variable
light chain
slc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2017558627A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018507254A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/015166 external-priority patent/WO2016126488A1/en
Publication of JP2018507254A publication Critical patent/JP2018507254A/ja
Publication of JP2018507254A5 publication Critical patent/JP2018507254A5/ja
Pending legal-status Critical Current

Links

JP2017558627A 2015-02-02 2016-01-27 抗代替軽鎖抗体 Pending JP2018507254A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562111018P 2015-02-02 2015-02-02
US62/111,018 2015-02-02
PCT/US2016/015166 WO2016126488A1 (en) 2015-02-02 2016-01-27 Anti-surrogate light chain antibodies

Publications (2)

Publication Number Publication Date
JP2018507254A JP2018507254A (ja) 2018-03-15
JP2018507254A5 true JP2018507254A5 (enExample) 2019-02-28

Family

ID=56564528

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017558627A Pending JP2018507254A (ja) 2015-02-02 2016-01-27 抗代替軽鎖抗体

Country Status (10)

Country Link
US (1) US10858448B2 (enExample)
EP (2) EP3253793A4 (enExample)
JP (1) JP2018507254A (enExample)
KR (1) KR102590740B1 (enExample)
CN (1) CN107849123A (enExample)
AU (1) AU2016215676B2 (enExample)
CA (2) CA2975346A1 (enExample)
HK (1) HK1247941A1 (enExample)
IL (1) IL253579A0 (enExample)
WO (1) WO2016126488A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016126488A1 (en) 2015-02-02 2016-08-11 Sea Lane Biotechnologies, Llc Anti-surrogate light chain antibodies
AU2016215110A1 (en) 2015-02-05 2017-09-21 Stc.Unm Anti-pre-BCR antagonists and methods
CN110352068A (zh) 2016-12-02 2019-10-18 南加利福尼亚大学 合成的免疫受体及其使用方法
JP7840511B2 (ja) * 2019-02-01 2026-04-06 石▲薬▼集▲団▼巨石生物制▲薬▼有限公司 抗クローディン18抗体及びそれらの使用の方法
AU2020266560A1 (en) * 2019-04-30 2021-11-25 Absci Corporation Cancer associated antibody compositions and methods of use
CN112300282A (zh) * 2020-11-03 2021-02-02 南京北恒生物科技有限公司 靶向cd7的人源化抗体及其用途
MX2023009433A (es) 2021-02-16 2023-11-29 Children´S Health Care D/B/A/ Children´S Minnesota Metodos para el tratamiento de b-all mediante la administracion de un antagonista del complejo pre-bcr.
US20260124303A1 (en) * 2022-10-04 2026-05-07 Mink Therapeutics, Inc. Fibroblast activation protein (fap) car-invariant natural killer t cells and uses thereof
WO2025212740A1 (en) * 2024-04-03 2025-10-09 Mink Therapeutics, Inc. Composition and methods for treating colorectal cancer liver metastasis (crc liver mets)

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2010A (en) 1841-03-18 Machine foe
US62950A (en) 1867-03-19 Improvement in apparatus foe the manufacture of vinegar
JPS60222842A (ja) 1984-04-19 1985-11-07 Fuji Photo Film Co Ltd ハロゲン化銀写真乳剤およびその製造方法
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4965188A (en) 1986-08-22 1990-10-23 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
US4800159A (en) 1986-02-07 1989-01-24 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences
DE3789138T2 (de) 1986-11-27 1994-05-26 Hoffmann La Roche Nukleotid-Sequenzen, die selektiv exprimiert sind in pre-B-Zellen und Sonden zu diesem Zweck.
US5182205A (en) 1986-11-27 1993-01-26 Hoffmann-La Roche Inc. Nucleotide sequences which are selectively expressed in pre-B cells and probes therefor
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US5780225A (en) 1990-01-12 1998-07-14 Stratagene Method for generating libaries of antibody genes comprising amplification of diverse antibody DNAs and methods for using these libraries for the production of diverse antigen combining molecules
US5427908A (en) 1990-05-01 1995-06-27 Affymax Technologies N.V. Recombinant library screening methods
US6172197B1 (en) 1991-07-10 2001-01-09 Medical Research Council Methods for producing members of specific binding pairs
GB9206318D0 (en) 1992-03-24 1992-05-06 Cambridge Antibody Tech Binding substances
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
US5698426A (en) 1990-09-28 1997-12-16 Ixsys, Incorporated Surface expression libraries of heteromeric receptors
DE69129154T2 (de) 1990-12-03 1998-08-20 Genentech, Inc., South San Francisco, Calif. Verfahren zur anreicherung von proteinvarianten mit geänderten bindungseigenschaften
PT100379B (pt) 1991-04-10 1999-01-29 Scripps Research Inst Bibliotecas de receptores heterodimericos usando fagomideos
US6492160B1 (en) 1991-05-15 2002-12-10 Cambridge Antibody Technology Limited Methods for producing members of specific binding pairs
US5871907A (en) 1991-05-15 1999-02-16 Medical Research Council Methods for producing members of specific binding pairs
US6225447B1 (en) 1991-05-15 2001-05-01 Cambridge Antibody Technology Ltd. Methods for producing members of specific binding pairs
US5858657A (en) 1992-05-15 1999-01-12 Medical Research Council Methods for producing members of specific binding pairs
PT1024191E (pt) 1991-12-02 2008-12-22 Medical Res Council Produção de auto-anticorpos a partir de reportórios de segmentos de anticorpo e exibidos em fagos
US5667988A (en) 1992-01-27 1997-09-16 The Scripps Research Institute Methods for producing antibody libraries using universal or randomized immunoglobulin light chains
US7067284B1 (en) 1992-01-27 2006-06-27 The Scripps Research Institute Methods for producing antibody libraries using universal or randomized immunoglobulin light chains
US5233409A (en) 1992-02-25 1993-08-03 Schwab Karl W Color analysis of organic constituents in sedimentary rocks for thermal maturity
US5733743A (en) 1992-03-24 1998-03-31 Cambridge Antibody Technology Limited Methods for producing members of specific binding pairs
GB9225453D0 (en) 1992-12-04 1993-01-27 Medical Res Council Binding proteins
US5516637A (en) 1994-06-10 1996-05-14 Dade International Inc. Method involving display of protein binding pairs on the surface of bacterial pili and bacteriophage
US6326155B1 (en) 1995-03-20 2001-12-04 Dyax Corp. Engineering affinity ligands for macromolecules
US6828422B1 (en) 1995-08-18 2004-12-07 Morphosys Ag Protein/(poly)peptide libraries
EP0859841B1 (en) 1995-08-18 2002-06-19 MorphoSys AG Protein/(poly)peptide libraries
JP2978435B2 (ja) 1996-01-24 1999-11-15 チッソ株式会社 アクリロキシプロピルシランの製造方法
GB9712818D0 (en) 1996-07-08 1997-08-20 Cambridge Antibody Tech Labelling and selection of specific binding molecules
JPH11133028A (ja) * 1997-10-29 1999-05-21 Sumitomo Electric Ind Ltd 抗ヒトプレb細胞レセプター抗体
WO1999006541A1 (fr) * 1997-07-29 1999-02-11 Sumitomo Electric Industries, Ltd. Anticorps du recepteur des cellules pre-b non humaines
US20030215453A1 (en) * 2002-05-14 2003-11-20 Dedera Douglas A. Methods of therapy and diagnosis using immunotargeting of cells expressing VpreB1 protein
GB2377997A (en) * 2001-07-24 2003-01-29 Bookham Technology Plc Connection of a non-perpendicular optical fibre to an optical device
JP4602614B2 (ja) 2001-09-26 2010-12-22 アイシン精機株式会社 自動車用ドア
JP4712724B2 (ja) * 2003-12-23 2011-06-29 クルセル ホランド ベー ヴェー CD1aに対するヒト結合分子
US8131480B2 (en) 2006-10-02 2012-03-06 Sea Lane Biotechnologies Llc Construction of diverse synthetic peptide and polypeptide libraries
AU2008230795B2 (en) 2007-03-27 2014-05-29 Bioassets, Llc Constructs and libraries comprising antibody surrogate light chain sequences
KR20110028543A (ko) 2008-07-11 2011-03-18 씨 레인 바이오테크놀로지스, 엘엘씨 항체 대용물 카파 경쇄 서열을 포함하는 구축물 및 라이브러리
US8969082B2 (en) * 2009-06-26 2015-03-03 Sea Lane Biotechnologies, Llc Expression of surrogate light chains
KR102011156B1 (ko) * 2011-01-06 2019-08-16 다이액스 코포레이션 혈장 칼리크레인 결합 단백질
WO2016126488A1 (en) 2015-02-02 2016-08-11 Sea Lane Biotechnologies, Llc Anti-surrogate light chain antibodies
AU2016215110A1 (en) * 2015-02-05 2017-09-21 Stc.Unm Anti-pre-BCR antagonists and methods

Similar Documents

Publication Publication Date Title
WO2016207304A3 (en) Monoclonal anti-il-1racp antibodies
JP2017176174A5 (enExample)
JP2013506428A5 (enExample)
JP2016505634A5 (enExample)
CY1120414T1 (el) Αντισωματα που συνδεονται me οχ40 και οι χρησεις τους
JP2012143232A5 (enExample)
NZ743713A (en) Human immunodeficiency virus neutralizing antibodies
UA105009C2 (uk) Композиції та способи, призначені для спрямованого впливу антитіл на білок с5 системи комплементу
AR084210A1 (es) PROTEINAS DE UNION AL TNF-a
NZ716369A (en) Anti-ox40 antibodies and methods of using the same
FI3332006T3 (fi) Uusia anti-PD-L1-vasta-aineita
JP2020516603A5 (enExample)
JP2010513228A5 (enExample)
EA201190132A1 (ru) Гуманизированные антитела, связывающиеся с cd19, и их применение
NZ587198A (en) Monoclonal antibodies against the rgm a protein and uses thereof
JP2021500916A5 (enExample)
JP2017518366A5 (enExample)
CO6231038A2 (es) Proteinas de union, incluyendo anticuerpos derivados de anticuerpo y fragmentos de anticuerpo que se unen especificamente a cd154 y sus usos
PE20071055A1 (es) Anticuerpos anti mn
NZ588713A (en) Antibodies to receptor of advanced glycation end products (rage) and uses thereof
ES2572231T3 (es) Anticuerpos monoclonales anti-IL-21 humana
JP2015527365A5 (enExample)
JP2010509937A5 (enExample)
TW200626614A (en) Human monoclonal antibodies to influenza M2 protein and methods of making and using same
JP2018504903A5 (enExample)